Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
Clinical trial NCT06551220 · RECRUITING
Trial details
- NCT number
- NCT06551220
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-10
- Primary completion
- 2026-07-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.